chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: FLU4
Symptoms: Underdose
Clinical narrative: 3 year old consumer getting a partial dose of Fluzone Quadrivalent; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 3 years old male patient who received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] and reported that 3 year old consumer getting a partial dose of Fluzone Quadrivalent (accidental underdose).  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On 15-Sep-2019, the patient received a dose of suspect 0.5 ml INFLUENZA QUADRIVAL A-B VACCINE lot UJ243AD and expiry date: 30-Jun-2020 via intramuscular route in the left deltoid.  It was a case of actual medication error due to accidental underdose.  It was unknown if the patient had any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none
Age: 60.0
Sex: U
Vaccine: MNQ
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Menactra vaccine has been dispensed for the use on a 60 year old consumer, no AE; Initial information received on 16-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 60 years old patient who was dispensed vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (lot number and Exp. Date not reported), on an unknown date.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a potential medication error case due to product dispensing error.  It was reported that the Menactra vaccine has been dispensed for the use on a 60 year old consumer.   It was unknown if the consumer has been administered this vaccine at the time of this report.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.
Sex: U
Vaccine: FLU4
Symptoms: Expired product administered, No adverse event
Clinical narrative: 2 patients received an expired flu from  last year, no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a non-health care professional.  This case involves two patients of an unknown demographics who received a dose of vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] expired from  last year on an unknown date (dose, route and site of administration, expiry date not reported).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was a case of actual medication error due to expired vaccine used.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.
Age: 12.0
Sex: U
Vaccine: DTAP, UNK
Symptoms: No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: 12 year old that received  Dtap instead of Tdap/ No AE; 12 year old that received  Dtap instead of Tdap/ no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 12 years old patient who received 0.5 ml dose of vaccines DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (lot C5254AB and expiry date: 18-Sep-2019) instead of DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE on 22-Jul-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant vaccination included MENINGOCOCCAL VACCINE A/C/Y/W CONJ (DIP TOX) (MENACTRA) for Immunisation.   It was an actual medication error due to wrong vaccine administered and Inappropriate age at vaccine administration.  At the time of reporting no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Age: 11.0
Sex: M
Vaccine: DTAP, TDAP
Symptoms: No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: by mistake gave Daptacel to an 11 yr old instead of Adacel, no AE; by mistake gave Daptacel to an 11 yr old instead of Adacel, no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 11 years old patient who received 0.5 ml dose of vaccines DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (lot U5798AB and expiry date: 15-Nov-2019) instead of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] via intramuscular route in the arm NOS by mistake on 13-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included MENINGOCOCCAL VACCINE B (MENINGOCOCCAL VACCINE B) for Immunisation.  It was an actual medication error due to wrong vaccine administered and inappropriate age at vaccine administration.  At the time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Age: 0.5
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: No adverse event, Product preparation issue
Clinical narrative: only Diluent diluent DTap/IPV of the Pentacel was received instead of Reconstituting with the HIB Powder, no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked with case 2019SA266039 (same reporter).   This case involves a 6 months old male patient received a dose of DTap/IPV from DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] instead of Reconstituting with the HIB Powder on 13-Sep-2019 via intramuscular route in right thigh while receiving his third dose of the series. The reported Lot numbers were for a Vial DTap/IPV (Lot: U6469AB, Expiration Date: 11-Oct-2020), Pentacel Box (Lot UJ134AAA, Expiration Date: 11-Oct-2020) and HIB Vial (Lot: UJ134AA, Expiration Date: 11-Oct-2020).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13), ROTAVIRUS VACCINE (ROTAVIRUS VACCINE); HEPATITIS B VACCINE (HEPATITIS B VACCINE) and INFLUENZA VACCINE INACT SPLIT VIRION 4V (FLUZONE QUADRIVALENT) for Immunisation on 13-Sep-2019.  It was an actual medication error due to inappropriate reconstitution technique.  At the time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Age: 14.0
Sex: F
Vaccine: MNQ
Symptoms: Expired product administered, No adverse event
Clinical narrative: expired dose of Menactra was inadvertently administered to patient, no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer (office staff).  This case involves a 14 years old female patient who was inadvertently administered with an expired dose of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (lot number not reported, expiry date: 30-Jun-2019), via unknown route in an unknown site on 15-Aug-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error due to expired vaccine used.  At the time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.
Sex: F
Vaccine: FLUR4
Symptoms: Expired product administered, No adverse event
Clinical narrative: given expired Fluzone Quadrivalent administered to patient / no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer.  This case is linked to case 2019SA262280.  This case involves a 4 years old female patient who was administered an expired INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] lot UT6375LA (Expiry date JUN-2019) via intramuscular route in the left thigh on 13-Sep-2019.  The patient's past medical history, vaccination(s) and family history were not provided.   It was a case of actual medication error due to expired vaccine used.  At a time of reporting No adverse reactions reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Sex: F
Vaccine: FLUR4
Symptoms: Expired product administered, No adverse event
Clinical narrative: given expired Fluzone Quadrivalent / no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer.  This case is linked to case 2019SA262273.  This case involves a 7 years old female patient who was administered an expired INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] lot UT6375LA (Expiry date JUN-2019) via intramuscular route in the left thigh on 13-Sep-2019.  The patient's past medical history, vaccination(s) and family history were not provided.   It was a case of actual medication error due to expired vaccine used.  At a time of reporting No adverse reactions reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort
Clinical narrative: tightness in the chest similar to when she has reactions to shellfish or peanuts; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a non-health care professional.  This case involves a 65 years old female patient who experienced tightness in the chest similar to when she has reactions to shellfish or peanuts, while she received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history included allergy to shellfish and peanuts, tightness in the chest . The patient's past medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX) for Immunization.  On 16-Sep-2019, the patient received a 0.5 ml dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (lot UJ232AB and Exp. Date 10-Apr-2020) via unknown route in the upper deltoid.  On an unknown date, the patient developed tightness in the chest similar to when she has reactions to shellfish or peanuts (chest discomfort) (Unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  The patient had a hospital visit.  Details of lab data not reported.  Final diagnosis was tightness in the chest similar to when she has reactions to shellfish or peanuts.   It was not reported if the patient received any corrective treatment.  On an unknown date, the patient had recovered from event.  List of documents held by sender: none.
Sex: F
Vaccine: FLU3
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 56 year age of patient receive Fluzone High Dose/ no AE; 56 year age of patient receive Fluzone High Dose/ no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 56 years old female patient who received vaccine 0.5 ml INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] lot UJ238AA (Expiry date 14-Apr-2020) via intramuscular route in the right deltoid on 07-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history and concomitant therapies were not provided.  It was an actual medication error case due to inappropriate age at vaccine administration and overdose.  It was reported that patient who is 56 years of age received the Fluzone HD.  The patient did not experience any adverse reaction.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Sex: F
Vaccine: FLU3
Symptoms: No adverse event, Product storage error
Clinical narrative: administration of Fluzone HD to patient that incurred a delayed transit / no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a non-hcp (Office Staff).  This case involves a 86 years old female patient who received 0.5 ml vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot UJ242AA) via intramuscular route in the right deltoid, on 16-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error case due to Incorrect product storage.  It was reported that administration of Fluzone HD that incurred a delayed transit time on 16Sep2019. Caller reports product was shipped on 12Sep2019 and was not received until 16Sep2019.  At the time of reporting none adverse event symptoms were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Sex: F
Vaccine: FLU3
Symptoms: Expired product administered, No adverse event
Clinical narrative: patient was given last year's Fluzone HD; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer.  This case involves Elderly female patient who was administered an expired INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot number and Expiry date unknown) via unknown route in unknown administration site on an unknown date.  The patient's past medical history, vaccination(s) and family history were not provided.   It was a case of actual medication error due to expired vaccine used.  At a time of reporting No adverse reactions reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.
Age: 4.0
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered, No adverse event
Clinical narrative: expired vaccines was inadvertently left in the refrigerator and was administered to 2 children, no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from other healthcare professional.  This case is linked to case 2019SA262370 (same reporter).  This case involves a four years old male patient who received 0.5 ml dose of expired vaccine QUADRIVALENT INFLUENZA VACCINE (FLUZONE QUADRIVALENT) (lot UT6375LA, Exp. Date 30-Jun-2019) via intramuscular route in the left vastus lateralis on 13-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  It was reported that a box of expired vaccines was inadvertently left in the refrigerator and was administered to 2 children on 9/13/2019.  At the time of reporting, no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Age: 1.42
Sex: M
Vaccine: FLU4
Symptoms: Expired product administered, No adverse event
Clinical narrative: nurse accidentally gave Fluzone Quadrivalent to a patient, that expired on 30Jun2019, no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from a non-healthcare professional.  This case involves a 17 months old male patient who received 0.25 ml dose of expired vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (Prefilled syringe, lot UT6259LA, Exp. Date 30-Jun-2019) via intramuscular route in the left thigh on 17-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13), HIB VACCINE CONJ (OMPC) (PEDVAXHIB) and DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DTAP) for Immunisation.  It was a case of actual medication error due to expired vaccine used.  It was reported that a nurse accidentally gave Fluzone Quadrivalent to a patient, that expired on 30-Jun-2019.  The patient did not experience any adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Age: 7.0
Sex: F
Vaccine: FLU4
Symptoms: Expired product administered, No adverse event
Clinical narrative: expired vaccines was inadvertently left in the refrigerator and was administered to 2 children, no AE; Initial information received on 17-Sep-2019 regarding an unsolicited valid non-serious case received from other healthcare professional.  This case is linked to case 2019SA262365 (same reporter).  This case involves a seven years old female patient who received 0.5 ml dose of expired vaccine QUADRIVALENT INFLUENZA VACCINE (FLUZONE QUADRIVALENT) (lot UT6375LA, Exp. Date 30-Jun-2019) via intramuscular route in left deltoid on 13-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was a case of actual medication error due to expired vaccine used.  It was reported that a box of expired vaccines was inadvertently left in the refrigerator and was administered to 2 children on 9/13/2019.  At the time of reporting, no adverse reactions were reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Fall, Head injury, Presyncope, Syncope
Clinical narrative: Fainted about 5 minutes after receiving vaccine (fell, hit head) - vagal response per paramedic Able to get up and leave, feeling better about 35 minutes after event.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Bone pain, Erythema, Fatigue, Pyrexia
Clinical narrative: Patient experienced low grade fever, erythema, bone pain for 36 hours and fatigue for 84 hours after vaccination.
Age: 57.0
Sex: M
Vaccine: FLUC4, VARZOS
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Swollen, painful lymph glands in the neck and face
Age: 65.0
Sex: M
Vaccine: FLU3
Symptoms: Back pain, Cough, Headache, Influenza A virus test, Influenza B virus test
Clinical narrative: Severe headache,fever.lower back pain,general all over body pain,coughing,thick secretions and mucus out of lungs[grayish-green color]
Age: 65.0
Sex: M
Vaccine: FLU3
Symptoms: International normalised ratio, Mucosal discolouration, Pain, Polymerase chain reaction, Productive cough
Clinical narrative: Severe headache,fever.lower back pain,general all over body pain,coughing,thick secretions and mucus out of lungs[grayish-green color]
Age: 65.0
Sex: M
Vaccine: FLU3
Symptoms: Pyrexia, Respiratory syncytial virus test
Clinical narrative: Severe headache,fever.lower back pain,general all over body pain,coughing,thick secretions and mucus out of lungs[grayish-green color]
Age: 10.0
Sex: F
Vaccine: UNK
Symptoms: Arthralgia, Asthenia, Erythema, Injection site pain, Pain
Clinical narrative: Localized rash, itching, redness and pain starting the day following vaccination. This lasted for 3 days, during which pt developed pain shooting down her arm to her wrist from vaccination site. Progressed to wrist pain and weakness that is gradually improving after 10 days.  Also c/o some aches and pains to legs but no weakness.
Age: 10.0
Sex: F
Vaccine: UNK
Symptoms: Pain in extremity, Pruritus, Rash
Clinical narrative: Localized rash, itching, redness and pain starting the day following vaccination. This lasted for 3 days, during which pt developed pain shooting down her arm to her wrist from vaccination site. Progressed to wrist pain and weakness that is gradually improving after 10 days.  Also c/o some aches and pains to legs but no weakness.
Age: 0.33
Sex: F
Vaccine: UNK
Symptoms: Diet refusal, Failure to thrive, Malnutrition, Pyrexia, Screaming
Clinical narrative: These were typical four month shots given. Our baby woke up the next morning with a 104.5 fever. She screamed for two days straight unless she fell asleep. She was admitted to Hospital due to refusing bottles for two days. She lost almost a whole pound and went into the ?Failure to thrive? and ?Malnourished? category.
Age: 0.33
Sex: F
Vaccine: UNK
Symptoms: Weight decreased
Clinical narrative: These were typical four month shots given. Our baby woke up the next morning with a 104.5 fever. She screamed for two days straight unless she fell asleep. She was admitted to Hospital due to refusing bottles for two days. She lost almost a whole pound and went into the ?Failure to thrive? and ?Malnourished? category.
Age: 77.0
Sex: M
Vaccine: VARZOS
Symptoms: Dry mouth, Dysphagia
Clinical narrative: Patient reported dry mouth and difficulty swallowing at 20 minutes after the vaccination.  The patient was monitored for 5 minutes and then it was determined to call EMS.  EMS arrived about 5 minutes after being called and took the patient to the hospital and assessing the patient.  No epinephrine was administered here at the pharmacy due to patient not presenting with difficulty breathing.
Age: 7.0
Sex: U
Vaccine: MMRV
Symptoms: Extra dose administered
Clinical narrative: I thought that i had picked up the MMR that is what i read on it but it was MMRV  I did not see the varicella on the box when i read it. so the patient was given varicella and extra dose.
Age: 71.0
Sex: M
Vaccine: VARZOS
Symptoms: Dizziness, Headache, Nausea, Pain, Pyrexia
Clinical narrative: Fever, achiness, nausea, dizziness, headache
Age: 36.0
Sex: F
Vaccine: TDAP
Symptoms: Chills, Pain, Vomiting
Clinical narrative: Vomiting, chills, and body aches began the morning after receiving the vaccine (about 20 hours after receiving). Vomiting resolved spontaneously after 1 hour. Chills and body aches for the remainder of the morning/afternoon, treated with Tylenol.
Age: 49.0
Sex: M
Vaccine: FLU4
Symptoms: Pyrexia
Clinical narrative: patient reported a high fever of up to 105 degrees F. on both Sunday and Monday. patient did not go to see a doctor . Patient reported still a fever on Tuesday but better than Monday and still did not want to go to see a doctor
Age: 14.0
Sex: F
Vaccine: FLU4
Symptoms: Erythema, Flushing, Peripheral swelling, Pruritus
Clinical narrative: left arm swelling with pink color and itchy 13x16 cm size; flushing of cheeks; given Benadryl at school and improved with less itching afterwards.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Headache, Pain, Photosensitivity reaction, Pyrexia
Clinical narrative: Fever, headache, achiness, arthralgias, photosensitivitu
Age: 62.0
Sex: F
Vaccine: FLU4, PNC13
Symptoms: Peripheral swelling, Pyrexia
Clinical narrative: Pt. presented to clinic 3 days after (9/20/19) with (R) arm swelling & fever. Tx'ed with cool packs, ibuprofen
Age: 35.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Oedema peripheral, Pruritus, Urticaria
Clinical narrative: Approximately 12 hours post injection the patient complained of itching of elbows, knees and hands.  Patient complained of pain in joints (specifically knees, elbows) and edema of hands which began on 9/20/19 at 6:00 am.  Patient presented with hives of knees, elbows and wrists on 9/20/19 at 1:00 pm.  Treated with diphenhydramine 50 mg Q 6 hours, ranitidine 150 mg QD and cetirizine 10mg QD. 9/21/19 the patient reported the symptoms had worsened (pain in joints worse, hives worse and spreading, edema of hands was worse.  Continued with the above treatment and also prednisone 40 mg one dose. The symptoms completely resolved by 9/22/19 at 2 pm.
Age: 58.0
Sex: F
Vaccine: FLU4
Symptoms: Body temperature increased, Vomiting
Clinical narrative: pt had a flu shot 09/21/2019. Her daughter called 09/24/2019 stating that mom has been throwing up since 09/23/2019 and her temp 99.4 she thinks it is related to shot. Pt will go to urgent care
Age: 56.0
Sex: F
Vaccine: FLU4, TDAP
Symptoms: Pyrexia, Rash
Clinical narrative: Rash, subjective fever
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Computerised tomogram, Facial paralysis, Influenza like illness, Pain
Clinical narrative: Patient states she experienced flu-like symptoms for 2 weeks after being immunized (8/27/19) with Shingrix. Aching, chills. Then she felt better for a while until 9/23/19. On the evening of 9/23, she states she starting experiencing facial drooping, difficulty talking. She went to ER, and after extensive tests, diagnosed her with Bell's Palsy.  She stated on the phone today that they discharged her last night, and she is on prednisone. Some of the symptoms have improved, but she still has some drooping and difficulty talking.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Speech disorder
Clinical narrative: Patient states she experienced flu-like symptoms for 2 weeks after being immunized (8/27/19) with Shingrix. Aching, chills. Then she felt better for a while until 9/23/19. On the evening of 9/23, she states she starting experiencing facial drooping, difficulty talking. She went to ER, and after extensive tests, diagnosed her with Bell's Palsy.  She stated on the phone today that they discharged her last night, and she is on prednisone. Some of the symptoms have improved, but she still has some drooping and difficulty talking.
Age: 81.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: The patient had a large red area just under where the immunization was given, the area was warm to the touch, but did not itch or burn.
Age: 31.0
Sex: F
Vaccine: FLU4
Symptoms: Influenza, Injection site pain
Clinical narrative: Had Flu symptoms 4 days after vaccination, soreness on the injection site and persisting up to this date.
Age: 37.0
Sex: F
Vaccine: TDAP
Symptoms: Asthenia, Chills, Headache, Mobility decreased, Nausea
Clinical narrative: Unsure if this was Adacel or Boostrix (only know "Tdap")  - great pain in arm, difficulty moving for a couple days - nausea, chills, headache, weakness
Age: 37.0
Sex: F
Vaccine: TDAP
Symptoms: Pain in extremity
Clinical narrative: Unsure if this was Adacel or Boostrix (only know "Tdap")  - great pain in arm, difficulty moving for a couple days - nausea, chills, headache, weakness
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Pruritus, Urticaria
Clinical narrative: Approximately 20 minutes after vaccine administration, patient developed generalized urticarial.  No respiratory or GI symptoms.  Re-evaluated in the office, normal cardiac and lung exam.  Diffuse urticarial and pruritus.  Given 5mg PO chewable Claritin and applied topical triamcinolone.  MOC called back about 3 hours later and symptoms had resolved.
Age: 84.0
Sex: M
Vaccine: FLUC4
Symptoms: Rash
Clinical narrative: Rash
Age: 89.0
Sex: F
Vaccine: FLUA3
Symptoms: Back pain, Chest pain, Erythema, Flushing, Pain in extremity
Clinical narrative: Shortly after receiving her flu shot (~within 5 minutes of receiving it), a patient came back and reported that she was feeling flushed and asked if she appeared red.  She seemed normal in appearance, but then she started complaining of severe lower back pain.  At this point, I asked her if she would like us to call an ambulance to which she responded, "yes."  I asked my technician to call 911, while I continued to assess the patient. I went out of the pharmacy to see if I could aid the patient to a chair in the nearby waiting area (5 steps away), but she complained her back was in too much pain, and she remained hunched over a shopping cart for support. Patient did not report difficulty breathing, dizziness, or nausea. I grabbed a chair and put it directly behind the patient so that she could sit down.  After sitting, patient reported the pain in her back moved to her legs.  And after a few more minutes of waiting, patient began to report she was experiencing chest pain.  Shortly after this, the paramedics arrived and took the patient to the hospital.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Lip swelling
Clinical narrative: swollen upper lip
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Incorrect route of product administration
Clinical narrative: The vaccination was administered subcutaneously rather than intramuscularly.  There was no immediate reaction noted.  The patient was consulted to contact the pharmacy if any reactions did occur and the prescriber was notified of the error.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Pyrexia, Rash
Clinical narrative: rash on face, trunk, back and legs, fever
Age: 75.0
Sex: M
Vaccine: FLU3, PPV, VARZOS
Symptoms: Injection site erythema, Injection site nodule
Clinical narrative: Patient received Flu and Pneumovax in right arm and then he got a large red knot at sight of injection. Patient went to emergency room and the doctor draw a circle of the red area and said it was 9 inch around. The doctor said if the red area went outside the circle to get script filled. The next morning the patient was not any better (red had not gotten bigger) and he decided to get script filled.
Age: 59.0
Sex: M
Vaccine: VARZOS
Symptoms: Amnesia, Blood test normal, Computerised tomogram normal, Headache, Influenza like illness
Clinical narrative: Early the morning following the vaccination had acute headache that lasted through Sunday. I rarely get headaches. Also, general ache and flu-like symptoms accompanied. Monday morning, I had a episode of Transient Global Amnesia and went to the emergency room for a quick onset and intense loss of memory. This lasted for about 2-3 hours and subsided, returning to normal by late day.
Age: 59.0
Sex: M
Vaccine: VARZOS
Symptoms: Magnetic resonance imaging normal, Pain, Transient global amnesia, X-ray normal
Clinical narrative: Early the morning following the vaccination had acute headache that lasted through Sunday. I rarely get headaches. Also, general ache and flu-like symptoms accompanied. Monday morning, I had a episode of Transient Global Amnesia and went to the emergency room for a quick onset and intense loss of memory. This lasted for about 2-3 hours and subsided, returning to normal by late day.
Age: 43.0
Sex: F
Vaccine: FLUC4
Symptoms: Injected limb mobility decreased, Insomnia, Pain in extremity
Clinical narrative: I have been having upper right arm pain for a while now, this has happened in the past, I cannot remember the exact year, but it was about  10 years ago, maybe. That pain lasted about 6 months and just went away on it's own. At the time I had mentioned it to my PCP but she said that she had never heard of arm pain after so many months  as a reaction to a flu shot. At that time, I could not even lift my arm to dress myself, it was very painful but like I said it went away. This time, I felt it again and thought oh no, before when I would tell people of my reaction to it before they looked at me like I was weird. This time I googled it and found that there is such a thing now.  This is where I got the information to this site. The deltoid muscle can get pinched and can be very painful. I knew I was not crazy. I am having pain now everyday, as the day goes on my arm just gets painful, there are times when I have to literally lift my arm up with my other arm to move it while I'm in bed. I have muscle relaxers that I was given by my PCP for my lower back pain that I use when the pain is so bad on my arm  and then I can get some sleep.  I have read articles on it and have found that a MRI can be helpful in determining how bad it is. I have not gone to my Dr yet regarding this and it's just because I do not want to take the time to do all the visits that will probably be involved and also the cost of the MRI. I have medical insurance but I'm sure there will be a deductible that I have to meet.
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pruritus, Injection site rash, Injection site warmth
Clinical narrative: patient experience some raise rash like localized to the right arm were injection was given 2 days after injection. heat would increase the itcheness
Age: 14.0
Sex: M
Vaccine: HEP, MNQ
Symptoms: Condition aggravated, Tic
Clinical narrative: Excessive tics following vaccine
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site discolouration, Injection site rash
Clinical narrative: RASH AT INJECTION SITE WHICH CAUSE A DISCOLORATION
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site warmth
Clinical narrative: Patient noticed redness, pain, and injection site was warm to the touch on Saturday the day after the injection.  She also said that the area felt hard.  This information was reported to the pharmacist on 9/16/19 and patient subsequently went to the physician's office on 9/17/19,
Age: 24.0
Sex: F
Vaccine: HPV9
Symptoms: Anxiety, Syncope
Clinical narrative: Patient fainted due to severe anxiety
Age: 32.0
Sex: M
Vaccine: FLUC4
Symptoms: Altered state of consciousness, Hyperhidrosis, Pallor
Clinical narrative: Patient was given shot and walked away to go get food, then came back within 5 minutes and sat in the waiting area. When approached he was pale and sweating. When asked if he was ok, he stated he felt like he was going to pass out. After sipping on some water and sitting on the floor, he never lost consciousness and spoke with us the entire time. After 10-15 minutes he was back up and feeling better, but still sweating. He was able to contact his fiancé who was waiting for him in the parking lot. He wanted to go grab food again and was last seen standing in line to purchase that food about 30 minutes after vaccination.
Age: 68.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Musculoskeletal pain, Neck pain, Pain
Clinical narrative: Patient reported sharp pain radiating from neck to r. shoulder blade that she believes is from the vaccine.  FLUHD in R ARM, pneumovax23 in left arm.  Pt notified pharmacy of reaction, gave her suggestions of icing area, treating with APAP and follow up with her primary care physician.  Additionally, I contacted DR office and let them know of the reaction (4pm 9/24/19).  Will be filing VAERS today.
Age: 50.0
Sex: F
Vaccine: PPV
Symptoms: Heart rate increased, Middle insomnia, Nightmare, Rash macular, Swollen tongue
Clinical narrative: Patient awakened after midnight on 9/10/19 with a swollen tongue.  She reported her heart was "beating out of her chest".  Patient had experienced nightmares leading up to the awakening.  She also reported having had nightmares during at least 1 night since the vaccination, but had not had any other symptoms until the 9/10/19 effects.  Patient reported skin blotches, primarily on her front & back.  She went to the ER after awakening with a swollen tongue.  The ER physician did not administer any treatments, although the nurse told the patient that "she has seen a lot of patients with reactions to the pneumo-23 vaccine".  Patient was not prescribed any medication to treat her reported symptoms.  As of 9/24/19, she does not report any lingering symptoms.
Age: 72.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Red swollen area on arm where vaccine was given. Patient will followup with medical provider.
Age: 12.0
Sex: M
Vaccine: TDAP
Symptoms: Injected limb mobility decreased, Injection site erythema, Injection site induration, Injection site swelling, Pain in extremity
Clinical narrative: Developed redness with a 6 inch round induration around site with obvious edges around 1/2 inch high same evening of injection. Entire upper arm became red and swollen. Left arm measured at 15 inches compared to right at 12 1/2 inches.  Arm was painful and difficult to move for several days.  At 3 days later, arm is no longer red but arm is firm/swollen but getting better
Age: 28.0
Sex: F
Vaccine: FLU4
Symptoms: Dyspnoea, Flushing, Palpitations, Tremor
Clinical narrative: Flushing in the face, shaking, heartbeat racing, and difficulty breathing. EMT took vitals, 92 heartbeat and 140/95 blood pressure. Drank water and rested. Symptoms decreased significantly within 30-45 minutes.
Age: 60.0
Sex: F
Vaccine: PPV
Symptoms: Chills, Pain in extremity
Clinical narrative: chills, severe arm pain
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Fatigue, Headache, Influenza like illness, Myalgia
Clinical narrative: Soreness,  redness Flu-like symptoms  (body aches, fatigue) Low grade fever- 100 degrees Muscle pain Headaches
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Pyrexia
Clinical narrative: Soreness,  redness Flu-like symptoms  (body aches, fatigue) Low grade fever- 100 degrees Muscle pain Headaches
Age: 17.0
Sex: F
Vaccine: FLU4, FLUR4
Symptoms: Injected limb mobility decreased, Injection site pain, Musculoskeletal pain
Clinical narrative: patient experienced severe pain in the shoulder due to possibility of nerve was hurt by the needle during immunization. patient reporting pain referring back to shoulder blade and she said she is unable to lift her arm above shoulder level
Age: 17.0
Sex: F
Vaccine: FLU4, FLUR4
Symptoms: Musculoskeletal pain, Pain in extremity, Tendonitis
Clinical narrative: patient experienced severe pain in the shoulder due to possibility of nerve was hurt by the needle during immunization. patient reporting pain referring back to shoulder blade and she said she is unable to lift her arm above shoulder level
Age: 42.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Patient received 2 immunizations on 9/23/19, flu in her right arm and pneumovax in her left arm. Patient came back to pharmacy 24 hours later and reported swelling and pain in her left arm. Suggested to patient  to ice area, take benadryl and ibuprofen. Patient will try those suggestions.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Coronary artery bypass, Dyspnoea, Dyspnoea exertional, Hypoxia, Rash
Clinical narrative: Pt received shingrix vaccine mid July through pharmacy.  Within two weeks, she experienced shortness of breath and vesicular rash on her face.  She had been able to walk 3 miles a day and now unable to walk across the room without SOB.  Pt had not had an asthma flare up in 40 years.  Using allergist as her PCP, allergiest  and diabetic resource.  Pt came two  Urgent Care after having difficulties for almost two months. She was hypoxic 88% and sent to hospital, admitted and a few days later having CABG
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash vesicular
Clinical narrative: Pt received shingrix vaccine mid July through pharmacy.  Within two weeks, she experienced shortness of breath and vesicular rash on her face.  She had been able to walk 3 miles a day and now unable to walk across the room without SOB.  Pt had not had an asthma flare up in 40 years.  Using allergist as her PCP, allergiest  and diabetic resource.  Pt came two  Urgent Care after having difficulties for almost two months. She was hypoxic 88% and sent to hospital, admitted and a few days later having CABG
Age: 66.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Back pain, Injected limb mobility decreased, Neck pain, Pain, Pain in extremity
Clinical narrative: Patient reports pain in both arms that radiates to her back and up to her neck. She says she has difficulty lifting her arms. Said she has not experienced and fever, chills, rash, or other symptoms. Patient says her physician told her to take Benadryl, and she reports also taking Aspirin.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Petechiae, Rash, Rash pruritic
Clinical narrative: RASH ON BOTH ARMS ON THE INSIDE OF THE ELBOW, PETICHAE ITCHY RASH
Age: 69.0
Sex: F
Vaccine: FLU3
Symptoms: Abdominal discomfort, Diarrhoea
Clinical narrative: Extreme GI upset with diarrhea
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Cellulitis
Clinical narrative: Pt went to the hospital and was diagnosed with cellulitis.
Age: 72.0
Sex: M
Vaccine: FLU3, PNC13
Symptoms: Dyspnoea, Pallor, Tremor
Clinical narrative: Around 3:15 pm , patient was given immunization of prevnar and fluzone high dose both in left deltoid as agreed to by the patient. about 5:20 pm patient's wife called rather frantic because he had become pale and shaky. Instructed her to lie him on his backs and rest his legs on the couch to help regain circulation to the upper portion of the body. A few minutes later the daughter got on the phone and said he was starting to have trouble breathing, so I instructed them to call 911 or got to the nearest emergency room due to the presentation of shortness of breath as I could not rule out some sort of reaction to the vaccination causing this.
Age: 13.0
Sex: F
Vaccine: UNK
Symptoms: Headache, Nausea, Pain, Pain of skin, Pyrexia
Clinical narrative: Tachycardia, rapid resp, ha, nausea, body aches, o skin painful to touch, fever
Age: 13.0
Sex: F
Vaccine: UNK
Symptoms: Respiratory rate increased, Tachycardia
Clinical narrative: Tachycardia, rapid resp, ha, nausea, body aches, o skin painful to touch, fever
Age: 76.0
Sex: F
Vaccine: FLU3
Symptoms: Contusion, Erythema, Peripheral swelling, Skin warm
Clinical narrative: Patient called pharmacy saying arm was bruised, swollen, red  and was hot to the touch .